March 11, 2024

FSD Pharma Multiple Sclerosis Candidate Safe and Well Tolerated

Biopharmaceutical company, FSD Pharma Inc. (Nasdaq: HUGE) has announced positive results from its Phase 1 study of Lucid-21-302 as a potential treatment to prevent disease progression in Multiple Sclerosis (MS) at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum. The company’s first-in-human dose escalation study enrolled healthy volunteers and concluded… [Read More]
March 11, 2024

MicroStrategy Buys 12,000 More Bitcoin for $821.7 Million

Software corporation MicroStrategy, has made its second-largest Bitcoin investment to date, purchasing an additional 12,000 Bitcoin for approximately $821.7 million. This acquisition increases the company’s total Bitcoin portfolio to approximately 205,000 tokens, valued at over $14 billion. The purchase was funded largely by the sale of $800 million in convertible notes through a private sale… [Read More]
March 09, 2024

Industry Momentum Sets Strong Pace for Biotech IPOs

Biotech companies launching IPOs in the first quarter of 2024 have been largely met with enthusiasm and optimism from investors. The first two months of the year have seen seven companies IPO in fields including gene editing, personalized medicine, and next-generation therapeutics. With advancements in CRISPR technology, companies investigating genetic therapies have become a focal… [Read More]
March 09, 2024

Clarus (CLAR) Tells Its Precision Sport Segment to Take a Hike, Repays All Debt, Focuses on Pure-Play Outdoor Business

Outdoor equipment and lifestyle retailer Clarus Corporation (CLAR) reported its Q4 and full year earnings. The company has sold its Precision Sport segment for $175MM which has allowed them to pay all debt and increase its cash position significantly to $11.3M. The Adventure segment generated its highest quarterly revenue, and the company intends to operate… [Read More]
March 08, 2024

Stocks in Motion: Lexaria Eyes Slice of $90B Weight Loss Market

Shares in innovative drug delivery platform company, Lexaria Bioscience (Nasdaq: LEXX), have been on the rise this week. The company is eyeing a slice of the booming obesity drug market which grew to an astonishing $90 billion in value in 2023, following the success of blockbuster GLP-1 drugs Ozempic® and Wegovy®. According to Lexaria, an… [Read More]
March 08, 2024

Athira Pharma Highlights Therapeutic Potential of Fosgonimeton for Alzheimer’s, Parkinson’s Diseases

Late clinical-stage biopharmaceutical company, Athira Pharma, Inc. (Nasdaq: ATHA), has presented new clinical data highlighting the therapeutic potential of fosgonimeton at the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders. Mark Litton, Ph.D., President and Chief Executive Officer of Athira, said, “Data presented at AD/PD, in tandem with the existing… [Read More]
March 08, 2024

OppFi’s Shares Tumble 19% Amid Lower-than-Expected 2024 Financial Projections

OppFi (NYSE: OPFI), a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans, experienced a significant decline in the company’s share price, dropping 19% to $3.06 during premarket trading. This drop followed the fintech company’s announcement of weaker financial expectations for 2024, attributed to consumer… [Read More]
March 08, 2024

Nasdaq 100 Drops 1% as Stock Market Rally Encounters Resistance: Market Overview

Unemployment in the US Reaches a Two-Year High Despite Strong Hiring Employment Growth Surpasses Forecasts with 275,000 New Jobs, but Wage Increases Slow Down The stock market retreated from its recent surge, which saw record highs, as investors processed a mix of employment data. The S&P 500 saw declines, particularly within the technology sector, its… [Read More]
March 08, 2024

TikTok Bill: House of Representatives to Cast Votes Next Week

As concerns over data privacy and national security continue to mount, the House of Representatives is poised to take action with a vote scheduled for next week on a bill aimed at tightening regulations on popular social media platform TikTok. The proposed legislation comes amid growing bipartisan support to address perceived threats posed by the… [Read More]